| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
| mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0006 |